✦ LIBER ✦

Mesalamine enema-induced exacerbation of ulcerative colitis

✍ Scribed by A. Bousseaden; F. Z. Ajana; W. Essamri; I. Benelbarhdadi; R. Afifi; M. Benazzouz; A. Essaid

Book ID: 106059786
Publisher: Springer
Year: 2009
Tongue: English
Weight: 45 KB
Volume: 24
Category: Article
ISSN: 0179-1958
DOI: 10.1007/s00384-009-0727-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Distribution of Mesalamine Enemas in Pat

Distribution of Mesalamine Enemas in Patients With Active Distal Ulcerative Colitis

✍ CHAPMAN, NICHOLAS J.; BROWN, MANUEL L.; PHILLIPS, SIDNEY F.; TREMAINE, WILLIAM J 📂 Article 📅 1992 🏛 Mayo Clinic 🌐 English ⚖ 535 KB

Mesalamine-induced pleuritis in a patien

Mesalamine-induced pleuritis in a patient with ulcerative colitis

✍ Alessandro Tozzi; Maria Rosa Biagini; Carlotta Rastelli; Andrea Galli; Donatella 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB 👁 2 views

Ecabet enema improves ulcerative colitis

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Gastrointestinal: Asymptomatic rectal pe

Gastrointestinal: Asymptomatic rectal perforation and massive pneumoretroperitoneum in patient with ulcerative colitis treated with mesalamine enemas

✍ Choi, YS; Lee, IT; Cho, KR; Kim, JK; Suh, JP; Lee, DS 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB

Treatment of ulcerative colitis with hyd

Treatment of ulcerative colitis with hydrocortisone enemas

✍ Richard G. Farmer; O. Peter Schumacher 📂 Article 📅 1970 🏛 Springer 🌐 English ⚖ 483 KB

Exacerbation of ulcerative colitis after

Exacerbation of ulcerative colitis after rituximab salvage therapy

✍ Martin Goetz; Raja Atreya; Maryam Ghalibafian; Peter R. Galle; Markus F. Neurath 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

Background: B-cells are considered to play a pathogenic role in human ulcerative colitis (UC) by producing autoantibodies that cause epithelial cell damage. Here we report on a patient with intractable UC who suffered from a severe exacerbation of UC after salvage therapy with rituximab, a B-cell-de